Human CD34 PharmaGenie ELISA Kit (SBRS0378)

Built on the PharmaGenie platform from Assay Genie, this quantitative immunoassay targets the human CD34 antigen, a glycosylated transmembrane sialomucin used as a marker of hematopoietic stem and progenitor cells. Researchers studying bone marrow reconstitution, cord blood enumeration, peripheral blood stem cell mobilization, and endothelial progenitor biology rely on CD34 quantification to track stem cell populations in transplantation workflows and regenerative medicine studies.

The reagent set is supplied in a microplate format that supports 96 individual determinations when standards, controls, and unknowns are processed in duplicate. It accepts cell culture supernatants along with plasma-derived and serum-derived matrices, supporting both in vitro work on cultured hematopoietic progenitors and measurements from whole-blood fractions. The signal is generated by an enzyme-linked substrate reaction read on a standard plate reader.

Each shipment includes a pre-coated plate, biotinylated detection antibody, recombinant standard, streptavidin-enzyme conjugate, wash buffer, substrate solution, and stop reagent, together with a printed protocol insert. Intended for research use only, the assay is not validated for diagnostic blood-bank release decisions without independent verification.